Deep Genomics sets up shop to marry deep learning and genomics

Deep Genomics has opened its doors. The University of Toronto spinout is working to explore the potential of applying deep learning to genomics, first as a way to improve genetic testing.

BGI CEO steps down to escalate interest in artificial intelligence

Jun Wang has stepped down as CEO of BGI. Wang, a 16-year veteran of BGI, led the business as it evolved into a dominant force in genomics, but has now decided to pursue his long-standing interest in artificial intelligence without the burden of also serving as CEO.

PCORI board signs off on $142.5M investment to scale up health data network

The board of governors at the Patient-Centered Outcomes Research Institute has signed off on an $142.5 million investment in PCORnet, an attempt to mine ever-growing repositories of health and clinical data for research.

SynBio startup Ginkgo Bioworks lands $45M to fuel push into pharma

Ginkgo Bioworks has landed $45 million in a Series B round. The money will facilitate a significant scaling up of operations at the synthetic biology pioneer, with an expansion into pharmaceuticals, construction of a second-generation lab and hiring of new staff all on the cards.

Oxford Nanopore raises $109M ahead of key period for its sequencing technology

Oxford Nanopore has added $109 million to its bank account, bringing the total raised to date up to $392 million and equipping the company for a vital period in its history

Google's Calico snags access to data to find genetic causes of long life

Google's life-extension biotech Calico has secured access to data held by, a family tree business that sells DNA testing kits. Calico will pick through the genetic data and millions of family trees in search of contributors to long life spans and drug targets.

Vermillion raises $18.8M to fund escalation of bioinformatics ambitions

Vermillion has tapped investors for money to fund the enhancement of its bioinformatics platform. The diagnostics and bioanalytics player pulled in a total of $18.8 million through a stock offering, a slice of which will be ploughed into biotech IT.

FDA turns to Google for help spotting adverse events

The FDA has approached Google for help identifying adverse drug events in search data. The regulator hooked up with Google to access the insights of Evgeniy Gabrilovich, an engineer at the tech behemoth who has published papers on the subject of mining search queries for adverse event reports.

AstraZeneca backs app to help people recover from heart attacks

The initiative sees the Big Pharma team up with Vida Health to push an app that helps people recover from heart attacks by guiding them through the weeks and months after the event, Fortune reports.

Illumina wraps lab automation and software around HiSeq X to lower barrier to mass sequencing

Illumina has introduced a suite of tools and software to help research organizations new to population-scale sequencing to get started with its HiSeq X Ten and Five systems. The move comes one month after BGI joined the large-scale sequencing field with a package that covers each step of the process, from sample preparation to data analysis.

Report: Danaher nears $30M buyout of computer-aided imaging business

Danaher has signed a letter of intent to buy Israeli computer-aided imaging player Applied Spectral Imaging for $30 million, according to Globes. The deal would give acquisition-hungry Danaher a way into the market for hardware and software to bolster the imaging capabilities of research labs.

Arivale sets up with $36M, A-list founders and one eye on the R&D potential of its 'dense data clouds'

With $36 million in the bank, Lee Hood as a co-founder and George Church on its scientific advisory board, Arivale is preparing to bring genome sequencing the public.

21st Century Cures Act clears House with data sharing, standardization sections intact

The U.S. House of Representatives has passed the 21st Century Cures Act by a huge majority, moving legislation that mandates the creation of a system for gathering and analyzing clinical trial data a step closer to coming into force.

Genomics vs. YouTube: Which will have the greater computing requirements in 2025?

YouTube users upload 300 hours of video every minute. If the site keeps growing at its current rate, researchers think users could be uploading 1,700 hours of video a minute by 2025, a total that would amount to 2 exabytes of data per year. Yet if a new analysis is right, the computing crunch facing genomics could dwarf these challenges.

Inventor of World Wide Web calls for U.K. government to revive NHS data-sharing plan

Sir Tim Berners-Lee has called on the U.K. government to re-energize its plans to share more data from the National Health Service with researchers.

Financially motivated hackers break into 3 major pharma companies in 18 months

More evidence has emerged that sophisticated hacking rings are targeting pharma companies for financial gain. The latest report accuses a hacking group of breaking into the systems of three major European pharma companies over the space of 18 months.

GSK working to build Apple's ResearchKit into its clinical trials

GlaxoSmithKline has revealed it is working to integrate Apple's ResearchKit into its clinical trials, setting it up to be one of the first drug developers to adopt the recently introduced platform. The Big Pharma sees the open-source research app as a useful tool for data collection.

Core Informatics snags $17.5M to fuel lab software land grab

Core Informatics has closed a $17.5 million Series B round to bankroll its campaign to capture an ever-growing slice of the LIMS and ELN markets. The cash will fund an across-the-board hiring spree and swell Core Informatics' current 65-strong headcount by 50% over the next 5 months.

China aims world's fastest supercomputer at genomics

The 33.86-petaflops supercomputer, which has topped the table of the world's fastest machines since its introduction in 2013, was used to cut the time it took to detect single nucleotide polymorphisms.

BioClinica mounts European expansion to push imaging and eClinical

BioClinica is making a push into Europe. The move entails the opening of new offices in London and Munich with a combined footprint of 1,400 square meters, from which it will provide image analysis and demonstrate its eClinical tools.